Lipids. Dalcetrapib raises HDL-cholesterol level, but does not reduce cardiac risk
- PMID: 23165074
- DOI: 10.1038/nrcardio.2012.171
Lipids. Dalcetrapib raises HDL-cholesterol level, but does not reduce cardiac risk
Comment on
-
Effects of dalcetrapib in patients with a recent acute coronary syndrome.N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5. N Engl J Med. 2012. PMID: 23126252 Clinical Trial.
References
-
- N Engl J Med. 2012 Nov 29;367(22):2089-99 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
